Berkshires Financial

Berkshire Hathaway earnings: Buffett’s quiet message to a loud market

Ruben Dalfovo
Ruben Dalfovo

Investment Strategist

Key takeaways

  • Record cash plus stock selling and no buybacks signal patience. Bills beat equities at today’s prices.

  • Insurance is doing the heavy lifting, and premiums held as float now earn interest.

  • Good deals are scarce and buybacks are on pause, so be selective. The signal turns when Berkshire restarts buybacks or announces a big acquisition.


Berkshire Hathaway reported third-quarter results on 1 November 2025. The headline is simple. Operating earnings rose and cash hit a fresh record near USD 382 billion. That mix signals caution on valuations and confidence in the insurance engine that funds the group.

Cash speaks louder than words

Third quarter total revenue increased 2.1% to almost USD 95 billion from USD 93 billion a year prior, while operating earnings rose 34% year on year to USD 13.5 billion, driven by stronger insurance underwriting and higher investment income on short-dated US T-bills.

The cash pile climbed to a record USD 381.7 billion, largely parked in very short Treasuries that now earn real income while Berkshire waits for price resets. Record cash alongside rising earnings sends a clear signal: management still sees few large, fairly priced opportunities.

Berkshire remained a net seller of equities in the quarter, offloading about USD 6.1 billion, and did not repurchase its own shares for a fifth straight quarter. That is another cautionary flag on valuation.

berkshire_equities_cash_2017_2025_y400

What it tells the market

Three messages matter beyond Berkshire.

Expected equity returns look middling at today’s prices. When a top allocator chooses bills over big buys, it hints that the risk-reward on public markets is fine, not compelling.

Deals are scarce at sensible prices. Berkshire is a net seller of equities for a 12th straight quarter, and buybacks remain on ice. That is a valuation tell.

Insurance is in a profitable part of the cycle. Combined ratios below 100 percent mean underwriting earns money before investment income, which lowers earnings volatility.

Under the bonnet

Insurance remains the workhorse. Reinsurance underwriting earnings improved sharply, helped by lower losses and tighter expenses. The 10-Q shows the property and casualty reinsurance combined ratio near 79% for the quarter, well below the 100% break-even line. Geico’s pre-tax underwriting profit fell 13% as costs rose, but its multi-year reset on pricing and claims remains intact.

Rails and utilities provide stability. Burlington Northern Santa Fe (BNSF) saw softer volumes in parts of the book, reflecting weaker demand in select freight categories and an unhelpful mix. Berkshire Hathaway Energy continues to manage higher interest expense and wildfire-related matters, including PacifiCorp litigation and insurance recoveries. These are steady, not flashy, and they matter for the conglomerate’s resilience.

Capital deployment stayed selective. In October Berkshire agreed to buy Occidental’s OxyChem petrochemicals unit for USD 9.7 billion in cash. That stands out because large, fairly priced deals have been scarce. OxyChem adds durable industrial cash flows alongside Lubrizol and shows the price discipline remains intact. Berkshire is willing to act, but only when the numbers clear a high bar.

Succession is set for continuity. Greg Abel becomes chief executive on 1 January 2026, while Warren Buffett remains chair. The structure signals steady governance and a culture that outlives any one manager. Abel brings regulated-asset and M&A experience, which fits Berkshire’s decentralised model. The next real tell for investors is how the company formalises investment authority across Abel, Todd Combs and Ted Weschler. That decision will tell you how capital is steered in the post-Buffett era.

 

Managers_BrK1
Sources: Company Filings, Bloomberg Intelligence and Saxo’s own estimates.
Why it matters for investors now

The macro read is straightforward. Cash yielding something again makes patience easier. That affects behaviour across the market: boards delay acquisitions, CFOs hoard liquidity, and investors demand more from every new equity dollar. If the easy money era is over, quality cash flows and pricing power matter more, and so does balance-sheet strength. Berkshire’s posture is a live case study of that shift.

There is another message. When underwriting improves, insurers’ surplus capital grows. That supports dividends and buybacks across the insurance sector and can tighten reinsurance capacity into 2026, influencing pricing power at renewals. Watch peers’ combined ratios and renewal commentary for confirmation.

Berkshire’s record cash and net equity selling reinforce a simple point. Top-tier allocators see better risk-adjusted returns in T-bills today than in many listed equities at current prices. That does not predict a market fall. It does suggest expected equity returns are lower than Berkshire would like.

At the same time, higher T-bill yields boost Berkshire’s investment income. That cushions earnings while the team waits for dislocations. Patience pays rent again.

Risks to watch for the wider market

Rapid rate cuts risk. If short-term rates fall fast, the cash-is-king maths weakens. Boards could chase deals again, and equity risk premia may compress at the wrong price. Early sign: a sharp drop in bill yields and a rebound in announced M&A.

Insurance shock season. A severe catastrophe run would raise loss costs, drain surplus, and tighten reinsurance capacity. That can ripple into credit, construction, and consumer pricing. Early sign: rising industry cat-loss tallies and weaker combined ratios at major reinsurers.

Policy and utility rulings. Adverse outcomes in US utility litigation or regulation could lift capital needs and dampen sector multiples. Early sign: fresh disclosures in filings and state-level rulings that push costs higher.

Investor playbook

  • Follow the buyback barometer. Track which quality companies pause or restart repurchases. A broad restart would hint that boards see value again.
  • Watch insurance pricing power. Strong combined ratios and firm reinsurance renewals support sector cash returns and can flag broader risk appetite.
  • Map cash to catalysts. High corporate cash balances plus any macro wobble can trigger selective M&A. Monitor large buyers with capacity and a history of discipline.
  • Prefer proven cash generators. When patience pays, companies with pricing power, clean balance sheets, and self-funded growth tend to win relative performance.

Patience pays again

Berkshire’s quarter is a quiet masterclass: make money the hard way in underwriting, let cash earn real income, and wait for prices that do the work for you. If the market keeps shouting, the patient will keep listening to the only thing that matters now: the cost of time. When short-dated bills pay real income, the opportunity cost of rushing into average deals rises. That slows mergers and widens the gap between great and merely good businesses. Investors should weigh patience as an active choice, not an absence of ideas.

The signal will flip when prices reset or stress appears. Berkshire’s first clues will be visible. A restart of buybacks or a sizable acquisition would tell you that expected returns have improved. Until then, record cash next to rising operating earnings argues for selectivity and strong balance sheets. For portfolio builders, the lesson is practical. Let cash earn its keep while you curate a shortlist of quality names and catalysts. Move when price meets process. Berkshire is not predicting a fall. It is reminding the market that discipline compounds.

This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.
The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options.

Quarterly Outlook

01 /

  • Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Quarterly Outlook

    Q4 Outlook for Investors: Diversify like it’s 2025 – don’t fall for déjà vu

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    Quarterly Outlook

    Q4 Outlook for Traders: The Fed is back in easing mode. Is this time different?

    John J. Hardy

    Global Head of Macro Strategy

    The Fed launched a new easing cycle in late Q3. Will this cycle now play out like 2000 or 2007?
  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.


Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.